Navigation Links
Amarin to Present at the Leerink Swann Hot Topics in Therapeutics Roundtable Conference
Date:2/7/2011

MYSTIC, Conn. and DUBLIN, Feb. 7, 2011 /PRNewswire/ -- Amarin Corporation plc (Nasdaq: AMRN) today announced that it is scheduled to participate in the Leerink Swann Hot Topics in Therapeutics Roundtable Conference on Wednesday, February 16, 2011. Amarin's participation includes both a panel discussion on Cardiology at 7:45am ET and a company presentation at 9:15am ET. The conference will be held at the Roosevelt Hotel in New York City.

A live audio webcast of the presentation will be available at the following URL:

http://www.wsw.com/webcast/leerink20/amrn

About AmarinAmarin Corporation plc is a clinical-stage biopharmaceutical company with expertise in lipid science focused on the treatment of cardiovascular disease. The Company's lead product candidate is AMR101, the active ingredient in which is ethyl-EPA (ethyl icosapentate). On November 29, 2010, the Company reported positive, statistically significant top-line results from the MARINE trial, the first of its Phase 3 clinical trials of AMR101. In the MARINE trial, AMR101 was investigated as a treatment for very high triglycerides (>500 mg/dL). AMR101 is presently being investigated in a second Phase 3 clinical trial, the ANCHOR trial, for the treatment of patients on statin therapy with high triglycerides (≥200 and <500mg/dL) with mixed dyslipidemia. The MARINE trial was, and the ANCHOR trial currently is, conducted under Special Protocol Assessment (SPA) agreements with the U.S. Food and Drug Administration (FDA). Amarin also has next-generation lipid candidates under evaluation for preclinical development.Investor Contact Information: Stephen SchultzInvestor Relations and Corporate CommunicationsAmarin CorporationIn U.S.: +1 (860) 572-4979 x292investor.relations@amarincorp.com Le
'/>"/>

SOURCE Amarin Corporation plc
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2

Related medicine technology :

1. Amarin Proceeding to Phase 3 With AMR101 for Hypertriglyceridemia
2. Amarin Corporation Appoints Colin W. Stewart as President and Chief Executive Officer
3. Amarin to Present at UBS Life Sciences Conference
4. Amarin Corporation to Host Investor Conference Call on Wednesday, November 10, 2010
5. Amarin to Present at Canaccord Genuity Cardiovascular, Diabetes & Obesity Conference
6. Amarin Prices Public Offering of American Depositary Shares
7. Amarin Announces Underwriters Exercise of Over-Allotment Option
8. Amarin Announces Successful Completion of Offering of American Depositary Shares
9. Amarin Provides 2010 Year-End Review to Shareholders
10. Vicus Therapeutics to Present at the 234th American Chemical Society National Meeting in Boston, MA
11. Lexicon to Present Research Results at American Chemical Society Meeting Regarding Target of LX1031 Drug Candidate
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/26/2014)... Nov. 26, 2014  Aethlon Medical, Inc. (OTCQB:AEMD), announced ... to raise approximately $3.3 million at a price of ... one institutional healthcare focused investor. Each unit consists of one ... share purchase warrant. Each whole warrant entitles the holder ... $0.30 for a period of five years from closing.  ...
(Date:11/26/2014)... 26, 2014  Cohen, Placitella & Roth, PC ... who purchased Nymox Pharmaceutical Corporation ("Nymox" or "Company") ... from January 31, 2011 through November 2, 2014 ... certain of its officers and directors publically disseminated ... Sections 10(b) and 20(a) of the Securities Exchange ...
(Date:11/26/2014)... THE WOODLANDS, Texas , Nov. 26, 2014 ... LXRX ) today announced the completion of previously ... of $280.0 million.  After fees and estimated offering ... million from the transactions.  The transactions consisted of: ... shares of common stock, pursuant to a registration ...
Breaking Medicine Technology:Aethlon Medical Announces $3.3 Million Equity Investment 2Aethlon Medical Announces $3.3 Million Equity Investment 3Cohen, Placitella & Roth, PC Investigating Nymox Pharmaceutical Corporation for Failing to Disclose Material Information 2Cohen, Placitella & Roth, PC Investigating Nymox Pharmaceutical Corporation for Failing to Disclose Material Information 3Lexicon Announces Completion Of $280 Million In Financing Transactions 2Lexicon Announces Completion Of $280 Million In Financing Transactions 3
... Tissue Oncology, Society held in Seattle, Washington demonstrates clinical ... single agent in patients with ... chemo-insensitive sarcomas, NEW YORK, Nov. ... preliminary data demonstrating the,tolerability and clinical activity of KRX-0401 (perifosine) in ...
... (ASX: PGL; Nasdaq: PGLA) today announced additional,data from the ... this,year. This data was presented at the 58th Annual ... Diseases in Boston, USA(1). As the Phase 2 ... data analysis described in this presentation was performed to,evaluate ...
Cached Medicine Technology:Keryx Biopharmaceuticals, Inc. Announces Positive Preliminary Phase 2 Data on KRX-0401 in Patients with Chemo-Insensitive Rare Sarcoma 2Keryx Biopharmaceuticals, Inc. Announces Positive Preliminary Phase 2 Data on KRX-0401 in Patients with Chemo-Insensitive Rare Sarcoma 3Keryx Biopharmaceuticals, Inc. Announces Positive Preliminary Phase 2 Data on KRX-0401 in Patients with Chemo-Insensitive Rare Sarcoma 4Keryx Biopharmaceuticals, Inc. Announces Positive Preliminary Phase 2 Data on KRX-0401 in Patients with Chemo-Insensitive Rare Sarcoma 5Keryx Biopharmaceuticals, Inc. Announces Positive Preliminary Phase 2 Data on KRX-0401 in Patients with Chemo-Insensitive Rare Sarcoma 6Progen Presents Additional Analysis of Data from PI-88 Phase 2 Liver Cancer Study at American Association for the Study of Liver Diseases 2Progen Presents Additional Analysis of Data from PI-88 Phase 2 Liver Cancer Study at American Association for the Study of Liver Diseases 3
(Date:11/28/2014)... Recently, BellasDress , a renowned dress manufacturer in ... line of cocktail dresses. In addition, these fresh dresses are ... free shipping on orders over $179. The aim of the ... is providing many styles of dresses, which come in various ... and more. All of them are on sale at affordable ...
(Date:11/28/2014)... Recently, PrettyTailor.com has developed and created its ... around the world in celebration of the coming holiday ... launched a special offer on all these outfits. ... pioneer in the garment industry, PrettyTailor.com brings together art ... and small. The business carries quite a few in ...
(Date:11/28/2014)... Nov. 28, 2014 (HealthDay News) -- People with diabetes face ... can help keep you healthy, an expert says. "With ... you,ll deal with the events, the family you,ll be visiting ... American Association of Diabetes Educators, said in an association news ... still be healthy." One idea is to make a ...
(Date:11/28/2014)... 29, 2014 BambooFlooringChina.com has been recognized ... industry. Recently, the business has announced its new ... offering big discount on these new models. , Based ... by hands, without carpenter machines involved. It is crafted ... is great for do-it-yourselfers without hard work on installation, ...
(Date:11/28/2014)... 2014 Dr. Diane Walder, one of ... the addition of Dr. Bridgit Nolan to her practice ... after having completed her dermatology residency at the University ... invited Dr. Nolan to join her practice ... cosmetic dermatology. Not only does Dr. Nolan strive to ...
Breaking Medicine News(10 mins):Health News:BellasDress Offers A Big Surprise By Updating Its Cheap and Charming Cocktail Dresses 2Health News:2015 Wedding Dresses from PrettyTailor.com Available Now 2Health News:Holiday Eating Tips for People With Diabetes 2Health News:BambooFlooringChina.com Introduces Its New Strand Woven Bamboo Flooring Collection 2Health News:Dr. Diane Walder Welcomes New Cosmetic Dermatologist to Practice 2
... June 25 The ,Help is Here Express, bus tour ... June 29 - July 3 at various cities in order ... programs that provide prescription medicines for free or nearly free. ... to 2.9 percent a year ago, the Partnership for Prescription ...
... al. Study Finds Dose High Enough to Cause Adverse Effect ... , , ARLINGTON, Va., June 25 The ... has emerged that phthalates may not affect the reproductive development ... rats and mice. A study by McKinnell et al. ...
... 2009)AcademyHealth and the Robert Wood Johnson Foundation have ... outstanding potential to contribute to the field of ... recipients each receive $1,000 for registration and travel ... PHSR Interest Group Annual Meeting, June 28-July 1, ...
... used to help identify women with diabetes during pregnancy ... screen the general population for unrecognized diabetes and prediabetes, ... used to help identify women with diabetes during pregnancy ... screen the general population for unrecognized diabetes and prediabetes, ...
... Community , , Multi-Platform Campaign Incorporates PSAs, Integrated ... June 25 Today, leading U.S. media companies ... in response to AIDS and promote specific calls-to-action to prevent ... Greater Than AIDS - a multi-faceted ...
... or flight, hormone may play a role, researcher suggests ... experienced physical abuse as children are more likely to ... a Canadian study. , The University of Toronto researchers ... 49 percent increased risk of cancer in adulthood. Even ...
Cached Medicine News:Health News:Partnership for Prescription Assistance Prepared to Help South Dakota Workers Hurt by Recession 2Health News:Partnership for Prescription Assistance Prepared to Help South Dakota Workers Hurt by Recession 3Health News:Partnership for Prescription Assistance Prepared to Help South Dakota Workers Hurt by Recession 4Health News:New Scientific Evidence Suggests Humans Resistant to Phthalate Effect on Lab Rodents 2Health News:Glucose challenge test is accurate and economical for diabetes and prediabetes screening 2Health News:Glucose challenge test is accurate and economical for diabetes and prediabetes screening 3Health News:New Media-Led Effort Responds to AIDS Crisis in Black America 2Health News:New Media-Led Effort Responds to AIDS Crisis in Black America 3Health News:New Media-Led Effort Responds to AIDS Crisis in Black America 4Health News:New Media-Led Effort Responds to AIDS Crisis in Black America 5Health News:New Media-Led Effort Responds to AIDS Crisis in Black America 6Health News:Abused Kids Face Higher Cancer Risk 2
The PYRAMETRIX PLUS instrument system is the next generation in design for disc space preparation and removal....
CD HORIZON SEXTANT Rod Insertion System...
Kerrison (Micro) Laminectomy Rongeur. 18 cm - 7 1/8, thick footplate, small handle, very delicate, 40 down-cutting, jaws 1 mm wide....
Schlesinger Laminectomie Rongeur, golden springs. 15 cm - 6, with narrow footplate, large handle, 40 down-cutting, jaws 3 mm wide....
Medicine Products: